XML 25 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1

Balance Sheet Components

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Balance Sheet Components

BALANCE SHEET COMPONENTS

Inventory

Inventory consisted of the following (in thousands):

			March 31, 2024						December 31, 2023
Finished goods			$	4,376					$	3,658
Work in progress			5,282						5,191
Raw materials			10,472						10,622
Total inventory			$	20,130					$	19,471

Accrued and Other Liabilities

Accrued and other liabilities consisted of the following (in thousands):

			March 31, 2024						December 31, 2023
Clinical studies			$	15,133					$	15,744
Short-term lease liability			6,054						5,943
Contingent consideration			6,050						5,469
Professional fees			4,390						5,911
Deferred revenue			4,356						4,748
Laboratory processing fees and materials			2,933						2,890
Deferred payments for intangible assets			920						920
Travel and expenses			891						—
Accrued shipping expenses			510						335
Accrued royalty			197						348
License and other collaboration fees			88						250
Capital expenditures			—						151
Other accrued expenses			4,148						2,788
Total accrued and other liabilities			$	45,670					$	45,497

X

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//210/tableOfContent

+ Details

Name:	us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration